Acetaminophen safety and hepatotoxicity - where do we go from here?

被引:82
作者
Amar, Patrick J. [1 ]
Schiff, Eugene R. [1 ]
机构
[1] Univ Miami, Miller Sch Med, Div Hepatol, Miami, FL 33136 USA
关键词
acetaminophen; hepatotoxicity; liver disease mechanism; metabolism; NSAIDs; overdose; paracetamol; safety;
D O I
10.1517/14740338.6.4.341
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acetaminophen has been widely used for > 50 years in the treatment of pain and fever and provides for the safe and effective relief of these symptoms. In a small minority of patients, however, acetaminophen is responsible for life-threatening liver injury and accounts for up to 50% of all adult cases of acute liver failure in the US. Although approximately two-thirds of adult overdoses are associated with suicide attempts, many are inadvertent, often due to the use of multiple acetaminophen formulations over many days. Additionally, some individuals appear to experience acetaminophen toxicity at 'therapeutic' doses of < 4 g/day, for reasons unknown. In pediatric populations, the overwhelming majority of acetaminophen overdoses are due to unintentional overdoses, except for the predominance of suicidal ingestions in the teenage population. This article seeks to review the mechanism and metabolism of acetaminophen and the features of toxicity in adults, pediatric and special populations. Additionally, expert opinion is presented herein to aid in reducing the frequency and severity of liver injury from acetaminophen.
引用
收藏
页码:341 / 355
页数:15
相关论文
共 86 条
  • [31] Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue
    Kobrinsky, NL
    Hartfield, D
    Horner, H
    Maksymiuk, A
    Minuk, GY
    White, DF
    Feldstein, TJ
    [J]. CANCER INVESTIGATION, 1996, 14 (03) : 202 - 210
  • [32] Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials
    Kuffner, Edwin K.
    Temple, Anthony R.
    Cooper, Kimberly M.
    Baggish, Jeffrey S.
    Parenti, Dennis L.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) : 2137 - 2148
  • [33] Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients - A randomized, double-blind, placebo-controlled trial
    Kuffner, EK
    Dart, RC
    Bogdan, GM
    Hill, RE
    Casper, E
    Darton, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (18) : 2247 - 2252
  • [34] Genetic predisposition to drug-induced hepatotoxicity
    Larrey, D
    Pageaux, GP
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 : 12 - 21
  • [35] Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
    Larson, AM
    Polson, J
    Fontana, RJ
    Davern, TJ
    Lalani, E
    Hynan, LS
    Reisch, JS
    Schiodt, FV
    Ostapowicz, G
    Shakil, AO
    Lee, WM
    [J]. HEPATOLOGY, 2005, 42 (06) : 1364 - 1372
  • [36] Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetarninophen toxicity
    Lei, Xin Gen
    Zhu, Jian-Hong
    McClung, James P.
    Aregullin, Manuel
    Roneker, Carol A.
    [J]. BIOCHEMICAL JOURNAL, 2006, 399 : 455 - 461
  • [37] AN ASSESSMENT OF THE SAFETY OF PEDIATRIC IBUPROFEN - A PRACTITIONER-BASED RANDOMIZED CLINICAL-TRIAL
    LESKO, SM
    MITCHELL, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12): : 929 - 933
  • [38] LEVY G, 1975, PEDIATRICS, V55, P818
  • [39] Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x
  • [40] MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185